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A B S T R A C T
The same anthelmintic treatment can have variable eﬃcacy on individual animals even if the parasite popu-
lation is homogenously susceptible. An extension of the R package eggCounts is proposed to take individual
eﬃcacy into account using a Bayesian hierarchical model. A simulation study is conducted to compare the
performance of ﬁve diﬀerent methods on estimating faecal egg count reduction and its uncertainty interval.
Simulation results showed the individual eﬃcacy model oﬀered robust inference to two diﬀerent data simulation
procedures with low root mean squared error on the reduction estimate and appropriate uncertainty estimates.
Diﬀerent methods were used to evaluate the anthelmintic resistance in a dataset from USA with sheep and cattle
faecal egg counts, where a strong anthelmintic resistance was detected. Open-source statistical tools were up-
dated to include the proposed model.
1. Introduction
Helminth infections impose burden on human and livestock popu-
lations, and their control often relies on periodic mass administration of
anthelmintics. Widespread anthelmintic resistance is now being re-
ported (Rose et al., 2015). An important test to diagnose anthelmintic
resistance is the faecal egg count reduction test (FECRT). Central to the
FECRT is the estimation of the abundance of eggs, usually expressed as
eggs per gram of faeces (epg) in helminth infected or potentially in-
fected hosts. Egg counts are also used for monitoring in epidemiological
studies and for developing alternative control methods that do not use
anthelmintics. Thus, the accuracy of techniques to estimate epgs and
hence the reduction will aﬀect the results of such studies.
The FECRT was established in the World Association for the
Advancement of Veterinary Parasitology (WAAVP) guideline (Coles
et al., 1992) and is a straightforward group-based method to evaluate
overall reduction of epgs. The FECRT is commonly used in practice and
it has been shown to provide robust estimation of reductions in
asymptotic settings (Levecke et al., 2012; Peña-Espinoza et al., 2016;
Wang et al., 2017). However, it neglects some of the nowadays well-
accepted issues, such as aggregation of egg counts between animals
(Morgan et al., 2005; Dobson et al., 2012) and Poisson errors from
sampling procedures (Torgerson et al., 2012). Improved formulations
have been proposed (Lyndal-Murphy et al., 2014; Levecke et al., 2015),
but those methods do not completely address these issues. In addition,
they cannot be used to obtain uncertainty estimates in some rare cases,
for example, when 100% reduction is observed or when sample stan-
dard deviation of both before- and after-treatment counts are zero.
Recently, there has be an advocacy of Bayesian methods to evaluate
FECR. Bayesian methods can address those issues and provide un-
certainty estimates when the FECRT cannot. At the moment, there are
two open-source R packages that are commonly used for evaluating
FECR, namely eggCounts (Torgerson et al., 2014; Wang and Paul, 2018)
and bayescount (Denwood et al., 2010). Peña-Espinoza et al. (2016)
showed the paired model from eggCounts has poor coverage prob-
ability, as a result of narrow uncertainty intervals when analysing da-
tasets with varying before- and after-treatment aggregation. Levecke
et al. (2018) showed the model does not provide diﬀerent inference
when after-treatment counts are randomly reordered. Those undesir-
able results arise because of its model assumption, which assumes the
same true eﬃcacy (or egg count reduction) for every animal within a
group. However, host related factors may eﬀect eﬃcacy. For example, it
has been shown that the level of feed intake can eﬀect the pharmaco-
kinetics and hence eﬃcacy in sheep (Ali and Hennessy, 1996). Diet has
also been shown to eﬀect the pharmacokinetics of benzimadazoles (e.g.
Oukessou and Chkounda, 1997). Thus, even if all animals in a
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population are infected by equally susceptible helminth parasites, there
may be variation in eﬃcacy between individual animals due to varia-
tions in feed intake or other factors. Furthermore, the species compo-
sition of helminth fauna may not have the same proportions in every
animal in a group and drug eﬃcacy may vary between helminth species
(Vidyashankar et al., 2012). The limitation of assuming the same true
eﬃcacy in humans was also discussed by Krücken et al. (2017) in a
study on school children. In such a population, eﬃcacy in individuals
may have greater heterogeneity, as the children were from a number of
diﬀerent villages attending diﬀerent schools, compared to a more
homogeneous population of sheep grazing a single pasture.
Currently the only choice of Bayesian hierarchical model allowing for
individual eﬃcacy is by Geurden et al. (2015) and is implemented within
the R package bayescount. However, the model recommends for replicated
samples for individual animals (Denwood, 2015). The package also con-
tains models that allow for varying before- and after-treatment aggrega-
tion, which can be a consequence of having individual eﬃcacy. Peña-
Espinoza et al. (2016) performed a simulation study comparing the paired
and unpaired models in the eggCounts package with bayescount varying-
aggregation model. However, the simulated data were generated under
the assumption of the bayescount model, with a compound gamma-
gamma-Poisson distribution and varying after-treatment aggregation. This
violated the assumptions of the eggCounts model, which created a mis-
match between the data and the model structure. Therefore, with such a
violation, it is reasonable to expect eggCounts models to have inferior
performance. The bayescount model provided better coverage probability,
but no results regarding bias or mean squared error was provided in their
simulation study. In this paper, we propose a new Bayesian hierarchical
model that takes individual eﬃcacy into account, while providing robust
estimation of reduction in egg counts. We further provide a reﬁned si-
mulation study, with improvements reﬂected in two aspects. Firstly, we
simulate datasets with two diﬀerent procedures, one with our model as-
sumptions and another with bayescount model assumptions. This en-
courages fair comparison between the methods. Secondly, we provide
comparison of root mean squared error (RMSE) on reduction estimates in
addition to coverage probabilities. This evaluates the methods in terms of
both bias and variance.
The aim of the present study is to propose and to evaluate an im-
proved Bayesian hierarchical model that addresses individual eﬃcacy
between animals. During this process, 1) we determine a suitable dis-
tribution for individual reduction of egg counts based on real dataset; 2)
we provide a fair and thorough comparison of existing Bayesian and
non-Bayesian methods against our proposed model; 3) we analyse a
recent dataset to determine its anthelmintic resistance status; and 4) we
oﬀer updated open-source tools for evaluating FECR and general ad-
vices for using Bayesian hierarchical models.
2. Materials and methods
2.1. Data description
The before- and after-treatment faecal egg count data were collected
from 287 sheep and 212 cattle, a total of 499 animals in 28 FECRTs (14
sheep FECRTs and 14 cattle FECRTs). All sheep tested were housed at
the University of Georgia Sheep Unit, Athens, Georgia, USA. Sampling
of sheep occurred between August 2011 and June 2015. Of the 14
FECRTs completed on sheep, 6 were completed with the high sensitivity
3 chamber modiﬁed-McMaster method (8 eggs per gram sensitivity)
and 8 were completed with the 2 chamber modiﬁed-McMaster method
(25 eggs per gram sensitivity). For modiﬁed-McMaster analysis, 4 g of
faeces were placed into a cup with 26mL (25 eggs per gram sensitivity)
or 25mL (8 egg per gram sensitivity) of sodium nitrate ﬂotation solu-
tion (speciﬁc gravity= 1.25–1.30, FECA-MED, Vedco, Inc., St. Joseph,
Missouri, USA). Homogenization of sample and sodium nitrate solution,
slide preparation, and counting were completed as previously described
(Noel et al., 2017). Cattle tests were performed on weaned stocker
cattle on properties in Georgia and Mississippi, USA as part of a study
addressing the use of composite faecal samples when performing a
FECRT (George et al., 2017). Faecal egg counts were performed as
described by George et al. (2017).
2.2. Proposed model
2.2.1. Determine the distribution of treatment eﬃcacy
Using pooled data, we empirically select a suitable distribution to
model treatment eﬃcacy of individuals. It is common to ﬁrstly model
the proportion of egg counts remaining after treatment, then subtract
the proportion from 1 to obtain the reduction of egg counts. We denote
this proportion as δi for the ith animal and compute it for each animal.
30 observations with zero before-treatment counts are excluded since
these reductions are not well deﬁned. In addition, 6 observations which
had more than 15-fold increase in after-treatment counts were also
excluded. Finally, a goodness-of-ﬁt statistic was used to determine a
suitable distribution based on the empirical cumulative distribution
function. Several candidate distributions were considered, including
gamma, inverse gamma, half-Cauchy, and half-normal distributions.
Based on the computed proportions from 463 pairs of counts, the best
ﬁtted distribution according to Cramér–von Mises distance is the
gamma distribution as shown in Fig. 1. A gamma distribution is then
used to model the reduction in our proposed Bayesian hierarchical
model.
Fig. 1. Fitted gamma distribution. Left: histogram of individual reductions with ﬁtted gamma distribution shown in red. Right: empirical quantiles with data points
against ﬁtted theoretical gamma quantiles, the =y x line is shown in red. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the Web version of this article.)
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2.2.2. Bayesian hierarchical model formulation
Suppose we have a group of animals from the same species with
sample size n, and their true epg follow some unimodal distribution. For
notational simplicity, the analytical sensitivity is assumed to be the
same throughout the sampling procedures. A faecal egg count (FEC) is
obtained twice from each animal with analytical sensitivity f , once
before applying treatment and once some days after treatment. We
denote the raw number of counts as ∗Yi C and ∗Yi T respectively, with
= …i n1,2, , . Given the true epg of sampled faeces before treatment YiC,
∗Yi C follows a binomial distribution with size YiC and probability f1/ .
This captures the counting variability, where the number of eggs
counted from diluted homogeneous samples is random. Then the true
epg of sampled faeces YiC follows a Poisson distribution with latent
mean μi, this addresses Poisson error, which arises because of randomly
distributed eggs within the faecal sample. Finally, the latent mean μi
follows a gamma distribution with shape κ and rate κ μ/ , which has
mean μ and variance μ κ/2 . The gamma distribution captures FEC ag-
gregation between animals. After treatment, we expect a change in the
latent mean of each animal. We take a random eﬀect model approach
and assume their treatment eﬃcacy is diﬀerent. The raw number of
counts ∗Yi T follow another binomial distribution with size YiT and
probability f1/ , where the true epg of sampled faeces after treatment YiT
follows a Poisson distribution with latent mean δ μi i. The new latent
mean allows each animal to have its own treatment eﬃcacy. The eﬃ-
cacies δi follows another gamma distribution as determined in section
2.2.1. with shape τ and rate τ ν/ .
The proposed Bayesian hierarchical model is formulated as,
│ =∗Y Y y Bin y f~ ( , 1/ ),i C iC iC iC
│ ∼Y μ Pois μ( ),iC i i
│ = ∼∗Y Y y Bin y f( , 1/ ),i T iT iT iT
│ ∼Y δ μ Pois δ μ, ( ),iT i i i i
│μ κ μ Gamma κ κ μ, ~ ( , / ),i
δ Gamma τ τ ν~ ( , / ).i
The median of reduction δi is computed based on the quantile
function of a gamma distribution, which then is used as the reduction
estimate. The model is implemented in R (R Core Team, 2018) using
Stan modelling language (Carpenter et al., 2017), which is a modern
computational tool for conducting Bayesian inference.
2.3. Simulation study
A simulation study is conducted to investigate the performance of
the proposed Bayesian hierarchical model. The proposed model is
compared against four other existing methods. Faecal egg counts are
simulated under two diﬀerent procedures, one that matches our model
assumptions with individual eﬃcacy and another that matches bayes-
count model assumptions. Generally speaking, models that have the
same assumptions as the simulation procedure have a natural ad-
vantage over models that assumes otherwise. Finally, the simulation
parameters are also varied within each procedure to cover a broader
range of possible scenarios.
The simulation is setup as follows. Procedure one: for each animal
before treatment, we ﬁrstly draw random samples of latent mean epg μi
from a gamma distribution with shape κ and rate κ μ/ . Then the true epg
from observed sample yi
C is drawn from a Poisson distribution with
mean μi. The observed count yi
C is simulated from a binomial dis-
tribution with probability f1/ and size yi
C. Since this is a paired design,
the latent mean epg μi remains the same for each animal after treat-
ment. We assume each animal experiences various levels of eﬃcacy,
hence the true epg from observed sample after treatment yi
T is now
simulated from a Poisson distribution with mean δ μi i, where δi is
sampled from a gamma distribution with shape τ and rate τ ν/ . Finally,
the observed count yi
T is simulated from a binomial distribution with
probability f1/ and size yi
T . Procedure two: we draw again random
samples of μi from a gamma distribution with shape κ and rate κ μ/ . The
true epg from observed sample yi
C follows a gamma-Poisson (i.e. ne-
gative binomial) distribution mean μi and dispersion κC, the level of
aggregation increases with decreasing κC. After treatment, yi
T is simu-
lated from another gamma-Poisson distribution with updated mean νμi
and aggregation κT . The observed counts are again simulated from a
binomial distribution. Such procedure allows a change of aggregation
before and after treatment.
For each procedure, we simulate FEC datasets with eight combina-
tions of parameters, each repeated 500 times. Speciﬁcally, we use latent
mean epg for the group =μ {150,500}, between animal aggregation
=κ {1,2} and mean reduction =ν {0.03, 0.15}. For procedure one, τ is
generated from a uniform distribution between 0.5 and 2.0 for each
simulated dataset, representing large to medium variability in eﬃcacy.
This leads to substantially to moderately increased FEC aggregation after
treatment. For example, when =τ 0.5 and the before-treatment ag-
gregation =κ 1, the observed after-treatment aggregation is reduced to
0.2. When =τ 2, the observed after treatment aggregation is only re-
duced to 0.5. For procedure two, there is no variability in eﬃcacy itself
hence a single ν is used. We set = =κ κ κC T to represent cases of no
change in FEC aggregation after treatment.
We assign a Beta(1,1) prior (equivalent to Uniform(0,1)) to the
mean reduction ν. We adapt the prior of μ and κ from Wang et al.
(2017). A weakly informative Gamma(1,0.001) is assigned to μ where
90% of the probability mass lies between 60 and 3000. A weakly in-
formative Gamma(1,0.7) prior is assigned to κ, where 90% of prob-
ability mass lies between 0.1 and 4.3, corresponding to substantial and
little aggregation. The shape parameter of reduction τ is often weakly
identiﬁed by faecal egg count data due its small sample sizes in prac-
tice, hence we assign a moderately informative prior zero-truncated
Normal(2,1), with 90% of probability mass lies between 0.36 and 3.6,
corresponding to large and small variability in eﬃcacy. This serves to
regularize the model and enhance its stability without interfere with the
result.
Next, we describe four additional existing methods to analyse the
simulated FEC datasets for comparison.
2.3.1. Faecal egg count reduction test
According to the WAAVP guideline (Coles et al., 1992), the per-
centage reduction in FECs can be calculated by − y y1 /T C, where y C
and yT are arithmetic means of before- and after-treatment counts. Its
95% uncertainty interval can be computed based quantiles of Student's
t-distribution with −n2 2 degrees of freedom and asymptotic variance
of their log ratio. This method is performed using fecrtCI() function in
the eggCounts package.
2.3.2. Asymptotic variance method
The asymptotic variance method by Levecke et al. (2015) assumed a
Poisson-negative binomial distribution of the observed FECs, and a
single reduction within a population. The authors derived asymptotic
expectation and variance of the reduction, and then computed its un-
certainty interval based on quantiles of a gamma distribution. The
shape and scale parameters of the gamma distribution are found via
moment matching. The asymptotic expectation is − y y1 /T C, which is
the same as the estimated reduction from FECRT. The asymptotic var-
iance is
⎜ ⎟⎜ ⎟ ⎜ ⎟ ⎜ ⎟⎛
⎝
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where s s,C T are the sample standard deviation of the before- and after-
treatment counts respectively. Cor y y( , )C T is the sample correlation
between before- and after-treatment counts.
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2.3.3. Model from bayescount package
The bayescount model assumes a compound gamma-gamma-
Poisson distribution, which matches with the procedure two of our si-
mulation study. The individual eﬃcacy model implemented in bayes-
count recommends replicated samples for individual animals, which is
not the spirit of our study, hence we select the model with ﬁxed eﬃcacy
but allowing diﬀerent aggregation. The level of aggregation is strongly
associated with the amount of variability in eﬃcacies, hence this does
not put the bayescount model in an unfavourable situation. The func-
tion fecrt.model() is used with setting paired.model, ﬁx.controls and
ﬁx.eﬃcacy all set to TRUE, while ﬁx.variation and zero.inﬂation set to
FALSE. Default weakly informative priors were used for the mean
parameters in the simulation study, while the default Beta(1,1) prior is
used for the reduction. The same Gamma(1,0.7) prior from our in-
dividual eﬃcacy model is used for the dispersion parameters to facil-
itate model comparison. Simulation results using default precision prior
from bayescount is in the Supplementary Material.
2.3.4. Model from eggCounts package
The eggCounts paired model is a special case of our proposed model
with a simplifying assumption. Instead of a gamma-distributed reduc-
tion δi, a single reduction is assumed for every animal. The function
fecr_stan() is used to analyse the simulated FEC datasets with setting
paired set to TRUE and zero.inﬂation set to FALSE.
The performance of our proposed individual eﬃcacy model is
compared against those four existing methods, in terms of the following
criteria: 1) RMSE on the reduction estimates of FEC; 2) coverage
probability of 95% conﬁdence interval for the case of non-Bayesian
methods and 95% credible interval for the case of Bayesian models,
they are collectively referred to as 95% uncertainty intervals (UIs); and
3) the width of UIs.
3. Results
3.1. Simulation results
The performance criteria are evaluated based on the simulation
results. Fig. 2 shows the width of 95% UIs and Fig. 3 shows their
coverage probabilities. Table 1 shows the RMSE based on their FECR
estimates. While generally one should not expect Bayesian credible
intervals to have the same frequentist properties, namely having 95%
coverage probability, we still compare them here since the estimation
of uncertainty for FECR is important in the decision-making process of
detecting anthelmintic resistance.
The width of 95% UIs diﬀer signiﬁcantly between diﬀerent
methods. Our proposed individual eﬃcacy model has moderate UI
width. The eggCounts model has very narrow intervals across all the
scenarios while the bayescount model has wide UIs under both simu-
lation procedures, which are consistent with the simulation study in
Peña-Espinoza et al. (2016). The asymptotic variance method and the
FECRT sometimes have extremely wide intervals when the true re-
duction is 85%. There are 14 and 89 intervals respectively that are
wider than 1 hence lie beyond the range of y-axis displayed in Fig. 2. An
untruncated version of the ﬁgure is provided in Supplementary Mate-
rial. Procedure two simulates the datasets with two separate gamma
distributions, hence more variability in observed counts is expected
compared to procedure one. The UIs have reasonable width when the
true reduction is 97%. However, 69 out of 4000 ×(500 8) simulations
resulted in undeﬁned UIs with the asymptotic variance and the FECRT
method. This occurs when all of the after-treatment counts are zero
such that the sample variance is undeﬁned.
Fig. 3 shows the coverage probabilities of those UIs, i.e. the per-
centage of datasets with the true reduction being within the estimated
UI. As it can be expected based on the width of their UIs, the eggCounts
model has low coverage probability while the bayescount model has
high coverage probability. As a result of their diﬀerences in model
assumption, the eggCounts model provides insuﬃcient coverage prob-
abilities for both procedures. The bayescount model has almost 100%
coverage when the datasets are simulated under procedure one, while it
has reasonable coverage under procedure two. The asymptotic variance
method also consistently provides insuﬃcient coverage probability, but
improved upon the eggCounts model. In contrast, the individual eﬃ-
cacy model has consistently reasonable coverage under both simulation
procedures. Based on both Figs. 2 and 3, our individual eﬃcacy model
can achieve good coverage probability with much narrower UIs, while
the bayescount model provides too wide intervals albeit having good
coverages.
As shown in Tables 1 and 2, the level of RMSE are comparable
across the methods, with bayescount model having higher RMSE when
simulated under procedure two. Our proposed individual eﬃcacy
model has small RMSE for all the scenarios. When simulating using
procedure one, the individual eﬃcacy model has lowest RMSE. The
model also has achieved low RMSE as well when simulating under
procedure two, which uses the compound gamma-gamma-Poisson dis-
tribution.
3.2. Evaluating FECR for the USA dataset
The dataset consists of 28 ﬂocks. Flocks here refer to both sheep
ﬂocks and cattle herds. Exploratory data analysis showed the ﬂock-wise
median reduction ranges from 100% to –322%, corresponding to
complete elimination of egg counts in the sample and a 2.22-fold in-
crease in egg counts after treatment. Within each ﬂock, the eﬃcacy
between animals also varied dramatically. Since individual eﬃcacy is
not a part of original eggCounts model assumption, it is not considered
in this evaluation. We also drop the asymptotic variance method in
favour of the more widely used FECRT. In order to allow for increased
egg counts in the FECR estimation, we place a Uniform(0,4) prior on ν
in the individual eﬃcacy model and the bayescount model. In practice,
one should carefully check if the pre-assigned prior includes the pos-
sible outcome of the current dataset. Fig. 4 shows the estimated FECR
along with UIs from four diﬀerent methods. Their estimates are mostly
similar, with the individual eﬃcacy model having smaller UIs in most
cases compared to the bayescount model.
Flock number 4, 5 and 28 result some discrepancies among the
models. Flock 4 consists of 15 animals, two of already-heavily infected
animals had a 4-fold and a 7-fold increase in egg counts respectively
after treatments. Since FECRT does not explicitly model the pairwise
relationship, the overall reduction is strongly inﬂuenced by those two
animals. This results in a higher after-treatment mean egg counts in the
ﬂock hence a negative reduction estimate. In ﬂock 5, 18 out of 19 an-
imals experienced an increase in their after-treatment FECs, with a
mean increase of 230%. There are 4 out of 19 animals that had less than
100% increase. The bayescount model was inﬂuenced by those ob-
servations hence the estimate is biased towards smaller increase. Since
our individual eﬃcacy model uses median reduction, it provides a
reasonable estimate and it is similar to the result from FECRT. Flock 28
consists of 13 animals, where all of the after-treatment counts are zero,
while there are only 3 non-zero before-treatment counts. Bayescount
model provides an extremely wide UI. This observation is consistent
with the simulation study, where bayescount model generally provides
much wider UIs especially when the before-treatment mean count is
low and reduction is large. Both the individual eﬃcacy model and the
FECRT provide reasonable estimates for ﬂock 28, but only former is
able to provide a valid UI.
4. Discussion
The eﬃcacies of anthelmintic treatments can be diﬀerent between
animals due to the factors discussed previously. In this paper, we pro-
posed an individual eﬃcacy model within a Bayesian hierarchical fra-
mework to analyse FECR. The model extended upon the original
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eggCounts paired model to allow varying individual eﬃcacy and oﬀers
robust estimation of the reduction in egg counts.
The original eggCounts model assumes every animal in the same
group has the same reduction, consequently there is a perfect correla-
tion between the latent before- and after-treatment epg. Although this
does not automatically suggest that observed counts are also perfectly
correlated due to Poisson errors in the sampling process, it does indicate
a strong correlation is expected. The correlation approaches 1 asymp-
totically as the observed FECs increases. In our pooled sample of FECs,
we observe a highly signiﬁcant correlation of 0.417 (p < 0.001) of the
observed counts, nevertheless it is much lower than 1, which indicates
that the individual eﬃcacy model we propose is a reasonable approach
to model this correlation and will give more robust results than the
assumption of equal eﬃcacy across all individuals.
The original eggCounts model provided narrow UIs on the reduction
estimate in all scenarios. The small uncertainty can be explained by its
model assumption, where a single reduction parameter is assumed for
every animal within the same group. Hence the variation is forcibly
captured by the dispersion parameter such that the uncertainty for re-
duction remains relatively small. The bayescount model has the ﬂex-
ibility of allowing varying before- and after-treatment aggregation.
However, in our simulation study with two diﬀerent simulation pro-
cedures, the model with varying aggregation consistently provided
wide UIs and slightly higher RMSE, which can lead to undesirable re-
sults of having many inconclusive decisions. One possible reason is that
the model has more hierarchical layers. With limited data available,
there is hardly any information on latent parameters of the model. In
addition, it uses mean reduction as the reduction estimate, this exposes
it to be easily inﬂuenced by extreme observations. For the bayescount
model, we have also experimented with ﬁx.eﬃcacy set to FALSE while
ﬁx.variation set to TRUE, and it did not lead to signiﬁcantly diﬀerent
results, suggesting the diﬀerent eﬃcacy between animals can be ef-
fectively addressed by either allowing for varying aggregation or
varying eﬃcacy itself. The FECRT is based on straightforward compu-
tation of the after- and before-treatment mean counts ratio, hence it
neglects features of the data generating process, such as individual ef-
ﬁcacy, between-animal aggregation and Poisson errors. The simulation
showed relatively good performance for the FECRT, but the method
also generated undeﬁned estimate and wider than 100% UIs. The
asymptotic variance method improved upon the FECRT and captures
some of the data generating process. However, it suﬀers the same
weakness as the FECRT which can generate undeﬁned reduction esti-
mates. Meanwhile, our newly proposed individual eﬃcacy model does
not suﬀer the constraint of having the same eﬃcacy for every animal,
which avoids the potential mismatch between model assumption and
data, hence leads to improvement in coverage probability.
When simulating under procedure two, separate gamma-Poisson
distributions are assumed for before- and after-treatment mean. This
leads a diﬀerence in the observed reduction, which is “heavy-tailed” as
a result of over-dispersion. When an extreme reduction is generated in a
dataset, the mean estimate of FECR can be strongly inﬂuenced by this
single observation. Although the bayescount method can eﬀectively
model the distribution in procedure two, it tends to generate biased
estimate of FECR hence having higher RMSE. However, for the original
eggCounts and the asymptotic variance/FECRT method, the pairwise
before- and after-treatment relationship is not explicitly modelled,
Fig. 2. Uncertainty interval widths of simulations. Boxplots of 95% uncertainty interval width, grouped by true reduction percentage, simulation procedure, before-
treatment mean and dispersion. Data outside the y-axis range are not shown. An untruncated version of the ﬁgure is available in Supplementary Material.
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hence mitigates this problem. Our individual eﬃcacy model uses
median reduction as the reduction estimate, providing robust inference
while take the pairwise relationship into account. The simulation study
showed superior performance of the individual eﬃcacy model com-
pared to other methods, it has low RMSE and reasonable UIs across all
the scenarios under both simulation procedures. Another advantage of
Bayesian models is that they allow a probabilistic view on the anthel-
mintic resistance status. Rather than providing an estimated reduction
and 95% UI as in the asymptotic variance/FECRT methods, the
Bayesian models provide entire distributions of the estimated reduc-
tion, which allows for the computation of anthelmintic resistance
probability given an arbitrary threshold.
When evaluating the present dataset, the FECR estimates were si-
milar across the individual eﬃcacy model, bayescount model and the
FECRT. This particular dataset contains ﬂocks with increased after-
treatment FECs, such that the commonly used Beta(1,1) prior for the
reduction is deemed inappropriate. Therefore, after exploring the da-
taset, we selected a Uniform(0,4) prior to allow for up to 3-fold in-
creased after-treatment mean epg. In practice, researchers should apply
Bayesian models with care. First of all, every Bayesian model comes
with assumptions and constraints from the model structure itself and
from the priors. For example, Wang et al. (2017) proposed zero-inﬂa-
tion models that deals with over-represented zero counts; the egg-
Counts paired model assumes the same reduction for every animal. As
shown in our simulation study, the paired model provides overly-
narrow UIs when the assumption is violated, which can lead to mis-
classiﬁcation in the end. In terms of prior constraints, researchers
should check if the priors at least cover the possible parameter values
observed from the dataset. For example, the default prior for modelling
reduction is Beta(1,1). This does not allow for increased mean epg after
Fig. 3. Coverage probability of simulations. Coverage probabilities of 95% credible or conﬁdence intervals, grouped by true reduction percentage, simulation
procedure, before-treatment mean and dispersion parameter.
Table 1
Root mean squared error of the faecal egg count reduction estimates from ﬁve diﬀerent methods, based on 500 simulations for each scenario under procedure one.
Procedure One Individual eﬃcacy eggCounts Bayescount asym.variance/FECRT
85% reduction =κ 1 =μ 150 0.0519 0.0602 0.0643 0.0602
=μ 500 0.0457 0.0565 0.0522 0.0565
=κ 2 =μ 150 0.0515 0.0573 0.0660 0.0579
=μ 500 0.0464 0.0486 0.0483 0.0487
97% reduction =κ 1 =μ 150 0.0171 0.0197 0.0309 0.0197
=μ 500 0.0113 0.0123 0.0211 0.0122
=κ 2 =μ 150 0.0149 0.0167 0.0297 0.0168
=μ 500 0.0110 0.0131 0.0171 0.0128
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treatment. In evaluating the present dataset, an alternative strategy is to
use Beta(1,1) prior only for those ﬂocks with reduced after-treatment
counts, and use Uniform(0,4) prior only for increased after-treatment
counts. We expect the ﬂocks with Beta(1,1) prior to have a slightly
narrower UIs compared to our analysis. Arguably this may not be of
clinical relevance because an increase in FECs after treatment clearly
indicates lack of anthelmintic eﬃcacy. However, the use of this in-
dividual eﬃcacy model would not be conﬁned to anthelmintic eﬃcacy
testing but could also be used for experiments where alternatives to
anthelmintics are used for parasite control and hence allowing for an
increase in FECs with the Uniform(0,4) prior adds additional ﬂexibility.
Secondly, researchers should be aware of the relevant contribution of
information from priors and data. This can be checked by plotting
posterior parameter distributions overlapped with corresponding prior
distributions (See section 4 in Wang and Furrer, 2018). While our de-
fault priors are weakly informative (except for τ which is moderately
informative) for most faecal egg count datasets, the relative contribu-
tion of information also depends on the data available (Gelman et al.,
2017). Researchers should ensure the priors used are sensible for their
data. Another potential issue with Bayesian models implemented using
Markov chain Monte Carlo (MCMC) sampling is that there can be
convergence problems. This can occur when there is limited informa-
tion available, including low counts and small sample sizes. The issues
can be detected by checking the eﬀective sample size of MCMC chains
(Gelman et al., 2014) and potential scale reduction factors (Brooks and
Gelman, 1998). The updated eggCounts package version 2.0 which
implemented the individual eﬃcacy model also has built-in warning
messages when convergence problems occur. We agree with Peña-
Espinoza et al. (2016), that unexperienced users should seek statistical
advice when problems occur, otherwise unreliable results could be
obtained. When there are convergence problems, a possible solution is
to further constrain the priors. In some cases, Monte Carlo simulation
can be used to obtain some information about the weakly identiﬁed
latent parameter from the data. This leads to empirical Bayes approach
(Carlin and Louis, 1997).
The proposed individual eﬃcacy model was extended based on the
predecessor eggCounts paired model, it is shown to have superior
performance in both the simulation study and when analysing the
Table 2
Root mean squared error of the faecal egg count reduction estimates from ﬁve diﬀerent methods, based on 500 simulations for each scenario under procedure two.
Procedure Two Individual eﬃcacy eggCounts Bayescount asym.variance/FECRT
85% reduction =κ 1 =μ 150 0.1011 0.1020 0.1488 0.1025
=μ 500 0.1053 0.0945 0.1360 0.0942
=κ 2 =μ 150 0.0607 0.0601 0.0846 0.0606
=μ 500 0.0689 0.0562 0.0737 0.0565
97% reduction =κ 1 =μ 150 0.0297 0.0268 0.0593 0.0269
=μ 500 0.0258 0.0214 0.0450 0.0214
=κ 2 =μ 150 0.0203 0.0204 0.0381 0.0204
=μ 500 0.0148 0.0139 0.0217 0.0139
Fig. 4. Analysis results of USA data. Analysis results of faecal egg count reduction from the individual eﬃcacy model, bayescount model and FECRT. Grey colored
uncertainty intervals and reduction estimates indicate the ﬂock is classiﬁed as anthelmintic resistant according to the WAAVP guideline, while black colored indicates
the ﬂock is classiﬁed as non-resistant, and there were no ﬂocks having suspected resistance.
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present dataset. The eggCounts package version 2.0 (Wang and Paul,
2018) and the online analysis tool (Torgerson et al., 2014; Furrer et al.,
2016) have been updated to include the newly proposed individual
eﬃcacy model, and a vignette to guide using the eggCounts package
was made available (Wang and Furrer, 2018). As we learn more about
the diﬀerent generating process of egg counts, the model used for FECR
evaluation should be continuously iterated to ensure model assump-
tions closely matches the actual data generating process.
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